People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Magnus Medical, Inc. | — | Biotechnology | Series C | $64.0M | $153.8M | 2025 |
| Ceribell, Inc. | — | Other Health Care | Series C | $52.5M | $975.9M | 2021 |
Xingjuan Chao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Xingjuan Chao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Firlik | 1 | 14 |
| Heath Lukatch | 1 | 10 |
| Juliet Tammenoms Bakker | 1 | 5 |
| Vikram Lamba | 1 | 4 |
| William Burke | 1 | 4 |
| Rebecca Robertson | 1 | 4 |
| Joseph Taylor | 1 | 3 |
| Joseph M. Taylor | 1 | 2 |
| David Stoffel | 1 | 2 |
| Christian Gormsen | 1 | 2 |
| Lucian Iancovici | 1 | 2 |
| Nolan Williams | 1 | 1 |
| Scott Blumberg | 1 | 1 |
| Raymond Woo | 1 | 1 |
| Josef Parvizi | 1 | 1 |
| Julie Tammenoms Bakker | 1 | 1 |
| Dan Rogy | 1 | 1 |
| Brandon Bentzley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.